William R. Wilcox

23.0k citations

377 papers · 15.4k · 2 hit papers · h-index 58

Impact in

Physiology top 0.2%
- Lysosomal Storage Disorders Research
Rheumatology top 0.2%
- Glycogen Storage Diseases and Myoclonus

Papers in

Materials Chemistry 119
- Solidification and crystal growth phenomena 75
- Crystallization and Solubility Studies 36
Molecular Biology 81
- Fibroblast Growth Factor Research 29

Co-authors: Dominique P. Germain (27 shared papers)Robert J. Desnick (8 shared papers)Chong E. Chang (11 shared papers)Maryam Banikazemi (10 shared papers)Gabor E. Linthorst (5 shared papers)Nathalie Guffon (5 shared papers)Pavel Krejčı́ (23 shared papers)Stephen Waldek (12 shared papers)
Journals: Journal of Crystal Growth (75 papers)Molecular Genetics and Metabolism (34 papers)The American Journal of Human Genetics (11 papers)Materials Research Bulletin (9 papers)Genetics in Medicine (9 papers)
Partner nations: United States France United Kingdom

In The Last Decade

William R. Wilcox

368 papers receiving 14.8k citations

William R. Wilcox's Hit Papers

align trajectories log scale

Fabry disease revisited: Management and treatment recommendations for adult patients 2018 · 401 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Molecular Genetics and Metabolism
2001 New England Journal of Medicine

Peers

Countries citing papers authored by William R. Wilcox

Since Specialization

Citations

This map shows the geographic impact of William R. Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Wilcox more than expected).

Fields of papers citing papers by William R. Wilcox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Wilcox. The network helps show where William R. Wilcox may publish in the future.

Co-authors

The 25 scholars most cited alongside William R. Wilcox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William R. Wilcox Line = papers co-authored together William R. Wilcox links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 377 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease New England Journal of Medicine ·Christine M. Eng, Nathalie Guffon, William R. Wilcox, Dominique P. Germain, Philip Lee, Steve Waldek, Louis R. Caplan, Gabor E. Linthorst, Robert J. Desnick Hit paper breakdown →	2001	1133
2	Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 Nature Genetics ·Patricia L. Tavormina, Rita Shiang, Leslie M. Thompson, Yazhen Zhu, Douglas J. Wilkin, Ralph S. Lachman, William R. Wilcox, David L. Rimoin, Daniel H. Cohn, John J. Wasmuth	1995	466
3	Agalsidase-Beta Therapy for Advanced Fabry Disease Annals of Internal Medicine ·Maryam Banikazemi, Jan Bultas, Stephen Waldek, William R. Wilcox, Chester B. Whitley, Timothy J. McDonald, Richard S. Finkel, Seymour Packman, Daniel G. Bichet, David G. Warnock, Robert J. Desnick	2007	418
4	Fabry disease revisited: Management and treatment recommendations for adult patients Molecular Genetics and Metabolism ·Alberto Ortíz, Dominique P. Germain, Robert J. Desnick, Juan Politei, Michael Mauer, Alessandro P. Burlina, Christine M. Eng, Robert J. Hopkin, Dawn A. Laney, Aleš Linhart, Stephen Waldek, Eric Wallace, Frank Weidemann, William R. Wilcox Hit paper breakdown →	2018	401
5	Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry Molecular Genetics and Metabolism ·William R. Wilcox, João Paulo Oliveira, Robert J. Hopkin, Alberto Ortíz, Maryam Banikazemi, Ulla Feldt‐Rasmussen, Katherine B. Sims, Stephen Waldek, Gregory M. Pastores, Philip Lee, Christine M. Eng, László Maródi, Kevin E. Stanford, Frank Breunig, Christoph Wanner, David G. Warnock, Roberta Lemay, Dominique P. Germain	2007	390
6	Hydrophobic moments and protein structure Faraday Symposia of the Chemical Society ·David Eisenberg, Robert M. Weiss, Thomas C. Terwilliger, William R. Wilcox	1982	360
7	Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease Journal of the American Society of Nephrology ·Dominique P. Germain, Stephen Waldek, Maryam Banikazemi, David A. Bushinsky, Joel Charrow, Robert J. Desnick, Philip Lee, Thomas Loew, Anouk C. Vedder, Rekha Abichandani, William R. Wilcox, Nathalie Guffon	2007	332
8	Long-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry Disease The American Journal of Human Genetics ·William R. Wilcox, (unknown), Maryam Banikazemi, Nathalie Guffon, Stephen Waldek, Philip Lee, Gabor E. Linthorst, Robert J. Desnick, Dominique P. Germain	2004	306
9	Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement Genetics in Medicine ·Christine M. Eng, Dominique P. Germain, Maryam Banikazemi, David G. Warnock, Christoph Wanner, Robert J. Hopkin, Jan Bultas, Philip Lee, Katherine B. Sims, Scott E. Brodie, Gregory M. Pastores, Joerg Strotmann, William R. Wilcox	2006	285
10	Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy Nephrology Dialysis Transplantation ·Raphael Schiffmann, David G. Warnock, Maryam Banikazemi, Jan Bultas, Gabor E. Linthorst, Seymour Packman, S. A. Sørensen, William R. Wilcox, Robert J. Desnick	2009	270
11	Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry Journal of Inherited Metabolic Disease ·Christine M. Eng, Janice M. Fletcher, William R. Wilcox, Stephen Waldek, C. Ronald Scott, David Sillence, Frank Breunig, Joel Charrow, Dominique P. Germain, Kathy Nicholls, Maryam Banikazemi	2007	262
12	Human Ehlers-Danlos Syndrome Type VII C and Bovine Dermatosparaxis Are Caused by Mutations in the Procollagen I N-Proteinase Gene The American Journal of Human Genetics ·Alain Colige, Aleksander L. Sieroń, Shi-Wu Li, Ulrike Schwarze, Elizabeth M. Petty, Wladimir Wertelecki, William R. Wilcox, Deborah Krakow, Daniel H. Cohn, William Reardon, Peter H. Byers, Charles M. Lapière, Darwin J. Prockop, Betty Nusgens	1999	261
13	Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease Journal of Medical Genetics ·Dominique P. Germain, Joel Charrow, Robert J. Desnick, Nathalie Guffon, Judy Kempf, Robin Lachmann, Roberta Lemay, Gabor E. Linthorst, Seymour Packman, C. Ronald Scott, Stephen Waldek, David G. Warnock, Neal J. Weinreb, William R. Wilcox	2015	253
14	Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life Genetics in Medicine ·Raymond Wang, Alicia Lelis, James Mirocha, William R. Wilcox	2007	229
15	Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing Genetics in Medicine ·Yuan Xue, Arunkanth Ankala, William R. Wilcox, Madhuri Hegde	2014	228
16	Clinical spectrum of fibroblast growth factor receptor mutations Human Mutation ·Maria Rita Passos‐Bueno, William R. Wilcox, Ethylin Wang Jabs, Andr�a L. Serti�, Luís Garcia Alonso, Hiroshi Kitoh	1999	222
17	Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry Pediatric Research ·Robert J. Hopkin, John J. Bissler, Maryam Banikazemi, L. Clarke, Christine M. Eng, Dominique P. Germain, Roberta Lemay, Anna Tylki‐Szymańska, William R. Wilcox	2008	216
18	Mutations in the gene encoding 3β- hydroxysteroid-Δ8,Δ7- isomerase cause X-linked dominant Conradi-Hünermann syndrome Nature Genetics ·Nancy Braverman, Paul Lin, Fabian F. Moebius, Cassandra Obie, Ann B. Moser, Hartmut Glossmann, William R. Wilcox, David L. Rimoin, Moyra Smith, Lisa E. Kratz, Richard I. Kelley, David Valle	1999	197
19	Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene Nature Genetics ·Eri Arikawa‐Hirasawa, William R. Wilcox, Alexander H. Le, Neil S. Silverman, Prasanthi Govindraj, John R. Hassell, Yoshihiko Yamada	2001	178
20	Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia Nature Genetics ·Matthew J. Rock, Jean Prenen, Vincent Funari, Tara Funari, Barry Merriman, Stanley F. Nelson, Ralph S. Lachman, William R. Wilcox, Soraya Reyno, Roberto Quadrelli, Alicia Vaglio, Grzegorz Owsianik, Annelies Janssens, Thomas Voets, Shiro Ikegawa, Toshiro Nagai, David L. Rimoin, Bernd Nilius, Daniel H. Cohn	2008	176

About William R. Wilcox

William R. Wilcox is a scholar working on Materials Chemistry, Molecular Biology, Genetics, Physiology and Mechanical Engineering, having authored 377 papers that have together received 15.4k indexed citations. Recurring topics across this work include Solidification and crystal growth phenomena (75 papers), Lysosomal Storage Disorders Research (58 papers), Connective tissue disorders research (52 papers), Crystallization and Solubility Studies (36 papers), nanoparticles nucleation surface interactions (32 papers), Fibroblast Growth Factor Research (29 papers), Metallurgical Processes and Thermodynamics (26 papers) and Carbohydrate Chemistry and Synthesis (24 papers). The work is most often cited by research in Physiology (5.2k citations), Rheumatology (2.6k citations), Cell Biology (2.0k citations), Genetics (2.8k citations) and Immunology and Allergy (478 citations). William R. Wilcox has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Dominique P. Germain, Robert J. Desnick, Chong E. Chang, Maryam Banikazemi, Gabor E. Linthorst, Nathalie Guffon, Pavel Krejčı́, Stephen Waldek, Daniel H. Cohn and David L. Rimoin. Their work appears in journals such as Journal of Crystal Growth, Molecular Genetics and Metabolism, The American Journal of Human Genetics, Materials Research Bulletin and Genetics in Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

William R. Wilcox

Impact in

Papers in i

In The Last Decade

William R. Wilcox

William R. Wilcox's Hit Papers

Peers

Countries citing papers authored by William R. Wilcox

Fields of papers citing papers by William R. Wilcox

All Works

About William R. Wilcox

Explore authors with similar magnitude of impact

Papers in